2015
Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases.
Goldberg S, Gettinger S, Mahajan A, Herbst R, Chiang A, Tsiouris A, Vortmeyer A, Jilaveanu L, Speaker S, Madura M, Rowen E, Gerrish H, Knapp-Perry E, Yao X, Chiang V, Kluger H. Activity and safety of pembrolizumab in patients with metastatic non-small cell lung cancer with untreated brain metastases. Journal Of Clinical Oncology 2015, 33: 8035-8035. DOI: 10.1200/jco.2015.33.15_suppl.8035.Peer-Reviewed Original Research
2009
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Nguyen D, Chiang A, Zhang X, Kim J, Kris M, Ladanyi M, Gerald W, Massagué J. WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis. Journal Of End-to-End-testing 2009, 138: 51-62. DOI: 10.1016/s9999-9994(09)20363-1.Peer-Reviewed Original ResearchLung adenocarcinomaMultiple organsWnt/TCF pathwayMonths of diagnosisPrimary lung adenocarcinomaLung adenocarcinoma metastasisLung adenocarcinoma cell linesLung adenocarcinoma progressionLung adenocarcinoma cellsWnt/TCFAdenocarcinoma cell lineGene expression signaturesBone metastasesTCF pathwayAdenocarcinoma metastasisDeterminant of metastasisLung tumorsAdenocarcinoma progressionMetastatic subpopulationsTumor growthMetastasisMetastatic capacityAdenocarcinoma cellsChemotactic invasionExpression signatures